XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Stockholders' equity at beginning of period at Dec. 31, 2018 $ 389,932 $ 3 $ (79,571) $ 348,397 $ 121,102
Shares at beginning of period (in shares) at Dec. 31, 2018   31,345,220 (3,947,460)    
Increase in stockholders' equity:          
Share compensation expense 2,806     2,806  
Exercise of stock options 37 $ 0   37  
Exercise of stock options (in shares)   3,000      
Common stock issued for vested restricted stock 0 $ 0   0  
Common stock issued for vested restricted stock (in shares)   215,071      
Common stock issued for vested performance shares 0 $ 0   0  
Common stock issued for vested performance shares (in shares)   13,267      
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (1,978) $ 0   (1,978)  
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (in shares)   (81,936)      
Repurchase of convertible notes, net of deferred taxes 36     36  
Purchases of treasury stock (10,629)   $ (10,629)    
Purchase of treasury stock (in shares)     (452,350)    
Net loss 3,497       3,497
Stockholders' equity at end of period at Mar. 31, 2019 383,700 $ 3 $ (90,199) 349,298 124,599
Shares at end of period (in shares) at Mar. 31, 2019   31,494,622 (4,399,810)    
Stockholders' equity at beginning of period at Dec. 31, 2018 389,932 $ 3 $ (79,571) 348,397 121,102
Shares at beginning of period (in shares) at Dec. 31, 2018   31,345,220 (3,947,460)    
Increase in stockholders' equity:          
Net loss 13,407        
Stockholders' equity at end of period at Sep. 30, 2019 383,049 $ 3 $ (105,679) 354,216 134,509
Shares at end of period (in shares) at Sep. 30, 2019   31,502,627 (5,101,583)    
Stockholders' equity at beginning of period at Mar. 31, 2019 383,700 $ 3 $ (90,199) 349,298 124,599
Shares at beginning of period (in shares) at Mar. 31, 2019   31,494,622 (4,399,810)    
Increase in stockholders' equity:          
Share compensation expense 2,425     2,425  
Common stock issued for vested restricted stock 0 $ 0   0  
Common stock issued for vested restricted stock (in shares)   5,789      
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (49) $ 0   (49)  
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (in shares)   (2,252)      
Repurchase of convertible notes, net of deferred taxes 66     66  
Purchases of treasury stock (15,480)   $ (15,480)    
Purchase of treasury stock (in shares)     (701,773)    
Net loss 5,067       5,067
Stockholders' equity at end of period at Jun. 30, 2019 375,729 $ 3 $ (105,679) 351,739 129,666
Shares at end of period (in shares) at Jun. 30, 2019   31,498,159 (5,101,583)    
Increase in stockholders' equity:          
Share compensation expense 2,531     2,531  
Exercise of stock options   $ 0   0  
Exercise of stock options (in shares)   7,019      
Common stock issued for vested restricted stock 0 $ 0   (55)  
Common stock issued for vested restricted stock (in shares)   (2,551)      
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (55)        
Net loss 4,843       4,843
Stockholders' equity at end of period at Sep. 30, 2019 383,049 $ 3 $ (105,679) 354,216 134,509
Shares at end of period (in shares) at Sep. 30, 2019   31,502,627 (5,101,583)    
Stockholders' equity at beginning of period at Dec. 31, 2019 383,312 $ 3 $ (109,239) 356,600 135,948
Shares at beginning of period (in shares) at Dec. 31, 2019   31,507,247 (5,277,438)    
Increase in stockholders' equity:          
Share compensation expense 4,608     4,608  
Exercise of stock options 381 $ 0   381  
Exercise of stock options (in shares)   32,000      
Common stock issued for vested restricted stock 0 $ 0   0  
Common stock issued for vested restricted stock (in shares)   247,224      
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (1,541) $ 0   (1,541)  
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (in shares)   (82,802)      
Repurchase of convertible notes, net of deferred taxes (190)     (190)  
Purchases of treasury stock (9,440)   $ (9,440)    
Purchase of treasury stock (in shares)     (489,662)    
Net loss (2,933)       (2,933)
Stockholders' equity at end of period at Mar. 31, 2020 374,197 $ 3 $ (118,679) 359,857 133,015
Shares at end of period (in shares) at Mar. 31, 2020   31,703,669 (5,767,100)    
Stockholders' equity at beginning of period at Dec. 31, 2019 383,312 $ 3 $ (109,239) 356,600 135,948
Shares at beginning of period (in shares) at Dec. 31, 2019   31,507,247 (5,277,438)    
Increase in stockholders' equity:          
Net loss 4,836        
Stockholders' equity at end of period at Sep. 30, 2020 386,473 $ 3 $ (118,679) 364,364 140,784
Shares at end of period (in shares) at Sep. 30, 2020   31,718,589 (5,767,100)    
Stockholders' equity at beginning of period at Mar. 31, 2020 374,197 $ 3 $ (118,679) 359,857 133,015
Shares at beginning of period (in shares) at Mar. 31, 2020   31,703,669 (5,767,100)    
Increase in stockholders' equity:          
Share compensation expense 2,319     2,319  
Common stock issued for vested restricted stock 0 $ 0   0  
Common stock issued for vested restricted stock (in shares)   8,105      
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (51) $ 0   (51)  
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (in shares)   (2,584)      
Net loss 951       951
Stockholders' equity at end of period at Jun. 30, 2020 377,417 $ 3 $ (118,679) 362,126 133,967
Shares at end of period (in shares) at Jun. 30, 2020   31,709,190 (5,767,100)    
Increase in stockholders' equity:          
Share compensation expense 2,298     2,298  
Exercise of stock options 24 $ 0   24  
Exercise of stock options (in shares)   2,000      
Common stock issued for vested restricted stock 0 $ 0   0  
Common stock issued for vested restricted stock (in shares)   10,528      
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (84) $ 0   (84)  
Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (in shares)   (3,129)      
Net loss 6,818       6,818
Stockholders' equity at end of period at Sep. 30, 2020 $ 386,473 $ 3 $ (118,679) $ 364,364 $ 140,784
Shares at end of period (in shares) at Sep. 30, 2020   31,718,589 (5,767,100)